profit from every $100 of sales.
$0$100
Hinge Health
$115.39-4.63% today
+184.1% in 1 year
1-year low $31.171-year high $123.23
Trading close to its highest price of the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2023 to 2025.
0%20% a year
It has no yearly profit to compare the price with.
CheapExpensive
It holds more cash than debt.
No debt5 years
Money in, money out
What Hinge Health sold, what it kept, and what it did with the cash.
Sales went from $293 million in 2023 to $588 million in 2025, with -$528 million of profit last year.
SalesProfit
Hinge Health handed back 39% of the cash it generated last year.
Buybacks $65M
Free cash flow 2025$165M
Bought back its own shares$65M
Paid as dividends–
Cash vs. debt$208M vs. $8M
Hinge Health vs. similar companies
How it compares with the largest companies in its industry.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
| Hinge Health | No profit yet | ||
 Veeva Systems | 53.7× · Expensive | ||
 Pro Medicus | 183.7× · Very expensive | ||
 M3 | 30.1× · Expensive | ||
 Doximity | 30.3× · Expensive |
AI analysis
An AI analyst reads Hinge Health's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of USD | 2023 | 2024 | 2025 |
|---|---|---|---|
| 293 | 390 | 588 | |
| 194 | 300 | 468 | |
| -131 | -32 | -546 | |
| -125 | -26 | -541 | |
| -108 | -12 | -528 | |
| -1.58 | -0.15 | -7.77 | |
| 66.3% | 76.8% | 79.6% | |
| -44.6% | -8.2% | -92.9% | |
| -36.9% | -3.1% | -89.9% |
Balance sheet
| In millions of USD | 2023 | 2024 | 2025 |
|---|---|---|---|
| Total assets | 623 | 673 | 745 |
| Cash | 235 | 301 | 208 |
| Total debt | 16 | 11 | 8 |
| Total liabilities | 195 | 257 | 366 |
| 427 | 417 | 379 | |
| 92 | 78 | 55 | |
| -23.3% | -5.9% | -111.7% | |
| -25.3% | -2.9% | -139.6% |
Cash flow
| In millions of USD | 2023 | 2024 | 2025 |
|---|---|---|---|
| -64 | 49 | 171 | |
| 5 | 4 | 6 | |
| -69 | 45 | 165 | |
| Dividends paid | – | – | – |
| 0 | 0 | 65 | |
| 2 | 1 | 643 |
Valuation
- –
- 58.4×
- –
- 26.0×
- 16.0×
- 56.7×
- –
- 1.8%
- -5.6%
- 0.0%
Profitability
- 79.6%
- -92.9%
- -89.9%
- -80.3%
- -114.5%
- -48.1%
- -138.7%
- -70.0%
- -167.8%
- 58.0%
Growth
- +41.7%
- –
- +277.5%
- –
- −22.9%
Financial health
- -0.4×
- 0.02
- 1.0%
- –
- 1.47
- 1.19
- 0.89
How it ranks in Healthcare
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Bottom 4%of 872
Top 14%of 868
Top 45%of 986
What analysts expect
- Average price target
- $56.88
- Range
- $45.00 – $68.00
- 6 analysts
These targets were collected on May 20, 2026 and our analyst feed has not updated since, so we no longer compare them with today's price.
Recent earnings
Our results feed has not updated since May 21, 2026. Results reported after that are not in this table yet.
| Date | EPS | Expected | Surprise |
|---|---|---|---|
| May 5, 2026 | 0.45 | 0.39 | +15.4% |
| Feb 10, 2026 | 0.49 | 0.04 | +1,125.0% |
| Nov 4, 2025 | 0.34 | 0.24 | +41.7% |
| Aug 5, 2025 | 0.67 | 0.09 | +644.4% |
| May 5, 2025 | 0.21 | – | – |
News
Texas turning blue may hinge on Democrats harnessing data center oppositionCNBC · Sep 23, 2026The newest story we have is from Sep 23, 2026.
Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
1/7Passes 1 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
31No pass
Benjamin Graham
30No pass
Philip Fisher
54No pass
Peter Lynch
73Pass
Joel Greenblatt
2No pass
Charlie Munger
40No pass
Terry Smith
34No pass
Questions about Hinge Health
Is Hinge Health a good stock to buy?
A business with weak numbers that is not profitable yet. 1 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Hinge Health AI analysis
What does Hinge Health do?
Hinge Health, Inc. focuses on building a health system that scales and automates the delivery of care using technology. It designs its platform to address musculoskeletal system care (MSK), including acute injury, chronic pain, and post-surgical rehabilitation. It is in Health Information Services, based in San Francisco, CA, United States, with 1,437 employees.
Does Hinge Health pay a dividend?
No. Hinge Health does not pay a dividend at the moment; in 2025 it returned $65.0 million to shareholders by buying back its own shares.
Is Hinge Health stock halal?
Yes. Hinge Health passes our halal screen: its business is permitted and its debt is under 0.1% of its market value, under the 30% limit. How we check
How has Hinge Health stock done over the past year?
Up 184.1% over the past twelve months, to $115.39. It traded between $31.17 and $123.23 and is 6.4% below its high.
Who are Hinge Health's competitors?
The largest listed companies in the same industry are Veeva Systems, Pro Medicus, M3 and Doximity. The peers table on this page compares their profit, growth and price with Hinge Health's.
Prices: daily closes to Nov 13, 2026. Fundamentals: company reports via invest-like data.